Ed Silverman

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office that oversees them

Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may be possible for Stealth to pursue accelerated approval.

In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and more.

The U.S. solicitor general agreed with the appeals court on three provisions of the state law that the PBM trade group had challenged.

A U.S. senator is asking the FDA how it will enforce regulations on pharmaceutical advertising after it let go of numerous employees from the office that oversees the issue.

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a common superbug

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

President Trump claimed his “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in a matter of weeks

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare diseases

Access to diabetes care in lower-income countries still lags for children, despite efforts from insulin makers.